Why FirstEnergy (FE) Stock Is Jumping Today

NEW YORK (TheStreet) -- Shares of FirstEnergy Corp. (FE) are higher by 3.52% to $31.78 in afternoon trading on Tuesday, after the company reported earnings of $64 million, or 16 cents per share for the 2014 second quarter, compared to a loss of -$164 million, or -39 cents per share for the year ago quarter.

The diversified energy company attributed its growth in earnings to strong performances from its distribution and transmission businesses. 

FirstEnergy said revenue for the most recent quarter remained the same year over year, at $3.5 billion.


Analysts polled by Thomson Reuters anticipated revenue of $3.32 billion. 

FirstEnergy reaffirmed its full year 2014 guidance for earnings in the range of $2.40 to $2.60 per share.

Analysts expect earnings of $2.47 per share for the year.

Separately, TheStreet Ratings team rates FIRSTENERGY CORP as a Hold with a ratings score of C. TheStreet Ratings Team has this to say about their recommendation:

"We rate FIRSTENERGY CORP (FE) a HOLD. The primary factors that have impacted our rating are mixed some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its revenue growth and increase in net income. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk, disappointing return on equity and poor profit margins."

FE ChartFE data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing